Vancouver, British Columbia and Rehovot, Israel – April 16, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced the signing of two agreements: a long term lease agreement for a new 80,000 square ft. facility in Yavne, Israel, and an […]
Vancouver, British Columbia and Rehovot, Israel – April 3, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced an early conversion of convertible debt notes, associated with the convertible debt financing rounds completed on October 2022, November 2022, July
BioHarvest Sciences Announces Conversion of Debt Notes Read More »
Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel – March 21, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of experienced life sciences executive
Vancouver, British Columbia and Rehovot, Israel – March 14, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it has been invited to participate in the Benzinga Virtual Healthcare Summit 2024 on March 20, 2024. Benzinga’s Virtual Healthcare Summit
Management Adding Critical Leadership Roles to Support Growth of Recently Launched CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel – March 13, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of two senior hires in the
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit Read More »
Vancouver, British Columbia and Rehovot, Israel – March 7, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on March 12-13, 2024. CEO Ilan
